Newark Aids Consortium Inc
Newark Aids Consortium: Strong Program Spending, but Transparency Lacking
EIN: 222903536 · Newark, NJ · NTEE: G81Z · Updated: 2026-04-04
| Metric | Value |
|---|---|
| Total Revenue | $12.1M |
| Total Expenses | $12.8M |
| Program Spending | 85% |
| Net Assets | $4.0M |
| Transparency Score | 75/100 |
Is Newark Aids Consortium Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Newark Aids Consortium Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Newark Aids Consortium Inc
Newark Aids Consortium Inc (EIN: 222903536) is a nonprofit organization based in Newark, NJ, classified under NTEE code G81Z. The organization reported total revenue of $12.1M and total assets of $7.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Newark Aids Consortium Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Newark Aids Consortium Inc is a large nonprofit that has been operating for 36 years, with 14 years of IRS 990 filings on record (2010–2023). Revenue has grown at a compound annual rate of 0.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $13.0M |
| Total Expenses | $12.8M |
| Surplus / Deficit | +$256K |
| Total Assets | $7.8M |
| Total Liabilities | $3.8M |
| Net Assets | $4.0M |
| Operating Margin | 2.0% |
| Debt-to-Asset Ratio | 48.4% |
| Months of Reserves | 7.3 months |
Financial Health Grade: A
In 2023, Newark Aids Consortium Inc reported a surplus of $256K with revenue exceeding expenses, holds 7.3 months of operating reserves (strong position), has a debt-to-asset ratio of 48.4% (moderate leverage).
Financial Trends
Over 14 years of filings (2010–2023), Newark Aids Consortium Inc's revenue has grown at a compound annual growth rate (CAGR) of 0.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +19.6% | +14.9% | +7.7% |
| 2022 | -2.0% | +6.8% | +41.3% |
| 2021 | +5.2% | +2.9% | +0.2% |
| 2020 | +18.0% | +7.3% | +35.6% |
| 2019 | -2.3% | -12.7% | -10.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1990 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Newark Aids Consortium Inc with a Mission Score of 75 out of 100 (Good). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Newark Aids Consortium Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $256K, with revenue exceeding expenses.
- Debt-to-asset ratio: 48.4%.
Executive Compensation Analysis
Without specific compensation figures for key executives in public filings, a precise assessment of executive compensation is not possible.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Newark Aids Consortium Inc's IRS 990 filings:
- Lack of detailed functional expense reporting in publicly available documents makes it challenging to fully verify spending allocations.
- Absence of annual reports or audited financials on their website limits public transparency and oversight.
Strengths
The following positive indicators were identified for Newark Aids Consortium Inc:
- Consistently high revenue generation, with over $10 million in revenue for most recent years.
- Maintains a healthy asset base, with total assets exceeding $7 million in 2023.
Frequently Asked Questions about Newark Aids Consortium Inc
Is Newark Aids Consortium Inc a legitimate charity?
Newark Aids Consortium Inc (EIN: 222903536) is a registered tax-exempt nonprofit based in New Jersey. Our AI analysis gives it a Mission Score of 75/100. It has 14 years of IRS 990 filings on record. Total revenue: $12.1M. 2 red flags identified. 2 strengths noted. Financial health grade: A.
How does Newark Aids Consortium Inc spend its money?
Newark Aids Consortium Inc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Newark Aids Consortium Inc tax-deductible?
Newark Aids Consortium Inc is registered as a tax-exempt nonprofit (EIN: 222903536). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Newark Aids Consortium Inc's spending goes to programs?
Newark Aids Consortium Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Newark Aids Consortium Inc compare to similar nonprofits?
With a transparency score of 75/100 (Good), Newark Aids Consortium Inc is above average for NTEE category G81Z nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Newark Aids Consortium Inc located?
Newark Aids Consortium Inc is headquartered in Newark, New Jersey and files with the IRS under EIN 222903536. It is classified under NTEE code G81Z.
How many years of IRS 990 filings does Newark Aids Consortium Inc have?
Newark Aids Consortium Inc has 14 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $12.1M in total revenue.
What does Newark Aids Consortium Inc do?
Newark Aids Consortium Inc is a nonprofit organization in the Diseases, Disorders & Medical Disciplines sector, located in Newark, New Jersey. It is classified under NTEE code G81Z.
How much revenue does Newark Aids Consortium Inc have?
Newark Aids Consortium Inc reported total revenue of $12,114,968. Based on 14 IRS 990 filings on record.
What are Newark Aids Consortium Inc's total assets?
Newark Aids Consortium Inc holds total assets of $7,304,426 as reported in IRS 990 filings.
Where is Newark Aids Consortium Inc located?
Newark Aids Consortium Inc is based in Newark, New Jersey.
What is Newark Aids Consortium Inc's EIN?
Newark Aids Consortium Inc's Employer Identification Number (EIN) is 222903536. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is Newark Aids Consortium Inc?
Newark Aids Consortium Inc is classified under NTEE code G81Z (Diseases, Disorders & Medical Disciplines).
Is Newark Aids Consortium Inc a registered 501(c)(3)?
Yes, Newark Aids Consortium Inc is recognized as a tax-exempt organization by the IRS. EIN: 222903536.
Does Newark Aids Consortium Inc file IRS Form 990?
Yes, Newark Aids Consortium Inc has 14 IRS Form 990 filings on record. The most recent covers tax period 202312.
What was Newark Aids Consortium Inc's revenue in 2023?
In the 202312 filing period, Newark Aids Consortium Inc reported total revenue of $13,028,512, total expenses of $12,772,829, and net assets of $7,773,875.
Is Newark Aids Consortium Inc's revenue growing or declining?
Newark Aids Consortium Inc's revenue is growing. Revenue went from $10,897,879 (202212) to $13,028,512 (202312), a +19.6% change. Based on 14 filings on record.
What is Newark Aids Consortium Inc's most recent 990 filing?
The most recent IRS Form 990 filing for Newark Aids Consortium Inc covers tax period 202312. It shows revenue of $13,028,512, expenses of $12,772,829, total assets of $7,773,875, and liabilities of $3,764,324.
How much does Newark Aids Consortium Inc spend on programs vs administration?
Based on IRS 990 analysis, Newark Aids Consortium Inc allocates approximately 85% of expenses to program services, 10% to administrative costs, and 5% to fundraising. This indicates strong program focus.
Is Newark Aids Consortium Inc a trustworthy charity?
Based on AI analysis of IRS 990 data, Newark Aids Consortium Inc appears trustworthy. Mission Score: 75/100 (Good). 2 red flags identified. 2 strengths noted.
What are the red flags for Newark Aids Consortium Inc?
The following concerns were identified: Lack of detailed functional expense reporting in publicly available documents makes it challenging to fully verify spending allocations.. Absence of annual reports or audited financials on their website limits public transparency and oversight.. These flags are based on automated analysis of IRS 990 public filings and should be verified independently.
What are Newark Aids Consortium Inc's strengths?
Positive indicators for Newark Aids Consortium Inc include: Consistently high revenue generation, with over $10 million in revenue for most recent years.. Maintains a healthy asset base, with total assets exceeding $7 million in 2023.. These findings are derived from AI analysis of the organization's financial filings.
How does Newark Aids Consortium Inc compensate executives?
Without specific compensation figures for key executives in public filings, a precise assessment of executive compensation is not possible. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
Given the consistent revenue and asset growth, what specific strategies are in place to ensure the long-term sustainability and expansion of their programs?
While the financial data shows strong revenue and asset figures, the public filings do not detail specific strategic plans for long-term program sustainability or expansion beyond general operational expenses.
Filing History
IRS 990 filing history for Newark Aids Consortium Inc showing financial trends over 14 years of public records:
Over 14 years of IRS 990 filings (2010–2023), Newark Aids Consortium Inc's revenue has grown by 11.1%, moving from $11.7M to $13.0M. Total assets increased by 15.2% over the same period, from $6.7M to $7.8M. Total functional expenses rose by 0.9%, from $12.7M to $12.8M. In its most recent filing year (2023), Newark Aids Consortium Inc reported a surplus of $256K, with revenue exceeding expenses. The organization holds $3.8M in liabilities against $7.8M in assets (debt-to-asset ratio: 48.4%), resulting in net assets of $4.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $13.0M | $12.8M | $7.8M | $3.8M | — | — |
| 2022 | $10.9M | $11.1M | $7.2M | $3.8M | — | View 990 |
| 2021 | $11.1M | $10.4M | $5.1M | $1.4M | — | View 990 |
| 2020 | $10.6M | $10.1M | $5.1M | $2.1M | — | View 990 |
| 2019 | $9.0M | $9.4M | $3.8M | $1.2M | — | View 990 |
| 2018 | $9.2M | $10.8M | $4.2M | $1.1M | — | View 990 |
| 2017 | $8.7M | $10.1M | $5.2M | $535K | — | View 990 |
| 2016 | $10.6M | $10.9M | $6.7M | $673K | — | View 990 |
| 2015 | $11.4M | $10.8M | $7.0M | $763K | — | View 990 |
| 2014 | $9.7M | $9.3M | $6.5M | $822K | — | View 990 |
| 2013 | $9.8M | $9.6M | $7.0M | $951K | — | View 990 |
| 2012 | $11.4M | $11.6M | $7.0M | $13.7M | — | View 990 |
| 2011 | $12.6M | $12.2M | $7.0M | $13.5M | — | View 990 |
| 2010 | $11.7M | $12.7M | $6.7M | $13.6M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $13.0M, expenses of $12.8M, and assets of $7.8M (revenue +19.6% year-over-year).
- 2022: Revenue of $10.9M, expenses of $11.1M, and assets of $7.2M (revenue -2.0% year-over-year).
- 2021: Revenue of $11.1M, expenses of $10.4M, and assets of $5.1M (revenue +5.2% year-over-year).
- 2020: Revenue of $10.6M, expenses of $10.1M, and assets of $5.1M (revenue +18.0% year-over-year).
- 2019: Revenue of $9.0M, expenses of $9.4M, and assets of $3.8M (revenue -2.3% year-over-year).
- 2018: Revenue of $9.2M, expenses of $10.8M, and assets of $4.2M (revenue +5.2% year-over-year).
- 2017: Revenue of $8.7M, expenses of $10.1M, and assets of $5.2M (revenue -17.8% year-over-year).
- 2016: Revenue of $10.6M, expenses of $10.9M, and assets of $6.7M (revenue -6.9% year-over-year).
- 2015: Revenue of $11.4M, expenses of $10.8M, and assets of $7.0M (revenue +17.2% year-over-year).
- 2014: Revenue of $9.7M, expenses of $9.3M, and assets of $6.5M (revenue -0.4% year-over-year).
- 2013: Revenue of $9.8M, expenses of $9.6M, and assets of $7.0M (revenue -14.6% year-over-year).
- 2012: Revenue of $11.4M, expenses of $11.6M, and assets of $7.0M (revenue -9.3% year-over-year).
- 2011: Revenue of $12.6M, expenses of $12.2M, and assets of $7.0M (revenue +7.5% year-over-year).
- 2010: Revenue of $11.7M, expenses of $12.7M, and assets of $6.7M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Newark Aids Consortium Inc:
Data Sources and Methodology
This transparency report for Newark Aids Consortium Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.